LENZ Therapeutics, Inc.

LENZ Therapeutics has registered zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting operational stability in our near-term detection window. However, absence of recent signals does not indicate absence of risk—our 90-day snapshot captures only the most recent period. The full $49 Report extends analysis to 12 months of filing history, calculates dilution risk scores based on equity issuance patterns, contextualizes all 8-K events, maps financing history and burn rate, and surfaces AI-detected risk signals across SEC documents. The full $49 Report adds comprehensive 12-month risk scoring, financing trajectory analysis, and institutional-grade dilution metrics.